U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español
Reuters Health Information Logo

"White-coat" hypertension not benign in diabetics

Printer-friendly version E-mail this page to a friend

Reuters Health

Tuesday, December 30, 2008

NEW YORK (Reuters Health) - White-coat hypertension is considered harmless in most people, but it appears to increase the risk of microvascular complications in patients with type 2 diabetes, Brazilian researchers report in Diabetes Care.

White-coat hypertension refers to the tendency for some patients who normally don't have high blood pressure to have a temporary increase in pressure while they are in their doctor's office.

Lead investigator Dr. Caroline B. Kramer told Reuters Health: "We believe that blood pressure levels are a strong predictor of chronic complications, and blood pressure should not be categorized only as normal or abnormal." Subtle changes such as white-coat hypertension or high-normal blood pressure should also be taken into account.

To examine the influence of white-coat hypertension, Kramer and her colleagues at Hospital de Clinicas de Porto Alegre identified 46 diabetic patients with blood pressures in the normal range during normal activity, but had elevated pressure in the office. These patients were compared with 117 patients who had normal blood pressure under both circumstances. None of the patients was taking antihypertensive medications.

While the groups did not differ in clinical characteristics or laboratory findings, the investigators report, the white-coat hypertensives had a higher average systolic blood pressure (the top number of a blood pressure reading) during daytime monitoring (126.6 versus 123.2 mm Hg) and during 24-hour ambulatory monitoring (124.7 versus 121.0 mm Hg).

After further analysis, they found that white-coat hypertension was associated with traces of protein in the urine and a nearly three-fold increased risk of developing diabetic retinopathy.

"Therefore," the investigators say, "white-coat hypertension should not be considered a harmless condition and treatment should be considered."

Kramer added that randomly assigned, double-blind studies are "needed to clarify a possible role of treating such conditions in type 2 diabetes mellitus."

SOURCE: Diabetes Care, December 2008.


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: